Long-term human survival cohorts and Phase 3 prevention trials covering UKPDS 34 / TAME Metformin AMPK longevity pathways, muscle protein synthesis across eight decades of life, and adult vaccine coadministration trials. Explore 817 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
The PC modeling approach offers flexible characterization of associations between longitudinal covariates, such as serially assessed tumor burden, and survival time.
MenACYW-TT booster induced robust immunogenicity against all serogroups, regardless of the primary vaccine received, and had an acceptable safety profile.
Ethical approval has been obtained from the Ethic Committee for Research with medicinal products of the University Hospital '12 de Octubre' (AC069/18) and from the Spanish Medicines and Healthcare Product Regulatory Agency...
The addition of probiotics to metformin therapy is associated with improvement in T2DM outcomes.
The results of this randomized controlled trial addressed controversy regarding the survival benefits of adjuvant sintilimab treatment for patients with resected locally advanced ESCC.
Current data advices for immunotherapy based regiments in patients with BRAF mutant melanoma or, possibly, sandwich approach.
QoL was not associated with survival in either treatment arm.
Among the 228 patients in the parent study, 107 were > 65 years.
M-stage at presentation had no association with survival in chemotherapy-naïve mCRPC.
We hereby.
122 individuals (22, 19, 20, 20, 20, 20, and 21 in each arm) completed a 90-day follow-up.
PFS for the Taiwanese participants of RELAY receiving RAM+ERL versus ERL+PBO was consistent with that in the overall RELAY population.
Surgical morbidity and mortality was comparable, whereas more non-surgical grade ≥ 3 side effects were observed with the combination, especially anorexia (A:1% B:11%), high blood pressure (A:4% B:13%) and infections (A:19% B:33%).
V114 is well tolerated and has a generally comparable safety profile to that of PCV13.
DeepTOP is open to provide a tractable framework for the development of other segmentation and predicting tools in clinical settings.
In patients with known heart and blood vessel disease (CVD), ezetimibe with a statin decreases major adverse heart and blood vessel events (MACE) but has no effect on all-cause and heart and blood vessel mortality, compared to...
In addition, PEG plus MP4 attenuated cognitive decline in women with mild cognitive impairment in a sixth RCT.
Among an expanded efficacy population, also identified post hoc, which included COVID-19-associated hospitalizations without a requirement for diagnostic polymerase chain reaction testing performed at the study central...
Data from this extended follow-up of the CT-P6 3.2 study demonstrate the comparable long-term efficacy of CT-P6 and reference trastuzumab up to 6 years.
NTG administration significantly improved the AMS score, whereas AF2 did not.
During this 12-month extension, lasmiditan was associated with a high rate of study completion, most attacks were treated with lasmiditan, and patients reported improvements in migraine-related disability and quality.
We also observed a similar and favorable safety profile in the T and R arms, with side effects being predominantly mild in severity and of gastrointestinal origin.
Ipatasertib plus abiraterone had an overall tolerable safety profile consistent with known toxicities.
Combination lenalidomide-vorinostat appeared to be poorly tolerated with more dose modifications, fewer cycles of maintenance therapy delivered and higher rates of discontinuation due to toxicity than lenalidomide alone.
This is the first trial to demonstrate the effectiveness of a bovine vaccine for schistosomiasis in reducing human schistosome infection.
VE in reducing pain medication use (39.6%; P -value: 0.008) and duration of medication use (49.3%, P -value: 0.040) was reported in the ZOE-70 study; corresponding positive VE estimates were observed in the ZOE-50 and ZOE-HSCT...
Immune responses after getting both at the same time of PCV20 and QIV were noninferior to separate administration of either vaccine.
Especially on day 120, PD-1 was upregulated on CD4 + T EMRA and T CM , and on CD8 + T EM and T CM cells; accordingly, proliferation and IFN-γ secretion capacities tended to decline after 4 months.
Sustained-release tramadol tablets with an immediate-release component are effective and well tolerated for managing postherpetic neuralgia.
Adding cetuximab to CAPOX and bevacizumab does not provide clinical benefit in patients with mCRC, even in the extended wildtype group with left-sided tumors.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
